CEACAM5 Antilichaam - N-terminalgebied: FITC (ARP30266_P050-FITC)

Carcinoembryonic antigen related cell adhesion molecule 5

CEA, CD66e

1048

P06731

NP_004354

Human, Horse

The immunogen is a synthetic peptide directed towards the N-terminal region of Human CEAM5

This gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, the encoded protein may regulate differentiation, apoptosis, and cell polarity. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants.

CEACAM6; CEACAM1; UQCC2; CD209; EWSR1; PTCHD2; HNRNPM

FITC: Fluorescein Isothiocyanate

Polyclonal Antibody

WB

Affinity purified

0.5 mg/ml

Horse: 90%; Human: 100%

Liquid. Purified antibody supplied in 1x PBS buffer.

All conjugated antibodies should be stored in light-protected vials or covered with a light protecting material (i.e. aluminum foil) . Conjugated antibodies are stable for at least 12 months at 4C. If longer storage is desired (24 months), conjugates may be diluted with up to 50% glycerol and stored at -20C to -80C. Freezing and thawing conjugated antibodies will compromise enzyme activity as well as antibody binding.

77kDa

Wet Ice

702

CEACAM5

CEACAM5

Rabbit

Carcinoembryonic antigen-related cell adhesion molecule 5

MESPSAPPHRWCIPWQRLLLTASLLTFWNPPTTAKLTIESTPFNVAEGKE